metastatic adenocarcinoma

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)

Not yet recruiting
  • Pancreatic Cancer
  • Metastatic Adenocarcinoma
  • Nab paclitaxel
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Mar 8, 2023

Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)

Recruiting
  • Pancreas Cancer
  • +3 more
  • Modified GCN+TTF treatment
  • Jacksonville, Florida
    Mayo Clinic
Apr 4, 2022

Advanced Adenocarcinoma, Metastatic Adenocarcinoma Trial in Philadelphia (Hydroxychloroquine (HCQ), Gemcitabine, Abraxane)

Completed
  • Advanced Adenocarcinoma
  • Metastatic Adenocarcinoma
  • Hydroxychloroquine (HCQ)
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Advanced Adenocarcinoma, Advanced Malignant Solid Tumor, Metastatic Adenocarcinoma Trial in Sacramento (Antineoplastic Vaccine,

Recruiting
  • Advanced Adenocarcinoma
  • +5 more
  • Antineoplastic Vaccine
  • Sargramostim
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 29, 2021

Gastric Adenocarcinoma, Metastatic Gastric Cancer, Metastatic Adenocarcinoma Trial in France (Atezolizumab + Ipatasertib,

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Atezolizumab + Ipatasertib
  • Atezolizumab + Bevacizumab
  • Dijon, France
  • +8 more
Mar 26, 2021

Metastatic Adenocarcinoma Trial (Belinostat, nivolumab, ipilimumab)

Withdrawn
  • Metastatic Adenocarcinoma
  • (no location specified)
Oct 26, 2020